New

Global ETF Survey 2026: Answer now →

Help us improve your experience. Please confirm your investor type:

Global ETF Survey 2026

The ETF Industry Is Evolving Fast

From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey.

Take the survey

›ETF Issuers›First Trust›MDEV

MDEV

First Trust Indxx Medical Devices ETF

Passive ETF Equity Theme: Healthcare Technology & Innovation

The MDEV Exchange Traded Fund (ETF) is provided by First Trust. It is built to track an index: Indxx Global Medical Equipment Index. The MDEV ETF provides physical exposure, so by buying it you actually own parts of all the 48 underlying holdings. This share class generates a stream of income by distributing dividends.

$19.64

+$0.18 (+0.94%) yesterday

1:30 PM 07/15/26 Closed

1D price range

$19.64$19.66

52W price range

$17.90$21.85

YTD Perf.

-7.28%

YTD Flows

Annualized volatility

Fund AuM

€2.6M

Share class AuM

€2.6M

TTM Yield

Tracking Error

Tracking Difference

Characteristics

ISIN

US33738R6392

TER

0.7%

Inception date

6/23/2021

Issuer

First Trust

Benchmark

Indxx Global Medical Equipment Index

Replication method

Dividend policy

Distributing

Compare similar ETFs

ETF Name	1w perf.
2B78 iShares Healthcare Innovation UCITS ETF	-3.14%
LIV Smart Healthcare Innovation ETF	-3.14%
FTXH First Trust Nasdaq Pharmaceuticals ETF	-4.43%
FOHW Franklin Future of Health and Wellness UCITS ETF	-1.83%
XDNA iShares Genomics Immunology and Healthcare Index ETF	-6.00%
IDNA iShares Genomics Immunology and Healthcare ETF	-5.04%
IHI iShares U.S. Medical Devices ETF	-5.85%
XDG3 Xtrackers MSCI Global SDG 3 Good Health UCITS ETF	-4.02%
DOCG L&G Healthcare Technology & Innovation UCITS ETF	-2.38%
HTEC Robo Global Healthcare Technology and Innovation ETF	-2.24%
CIB0 Vaneck Bionic Engineering Ucits ETF	-3.93%
IHE iShares U.S. Pharmaceuticals ETF	-4.42%
CBUF iShares MSCI World Health Care Sector Advanced UCITS ETF	-3.61%
PINK Simplify Health Care ETF	-2.15%
HEAL Global X Telemedicine & Digital Health ETF	-3.87%

API

PerformanceDec 31, 2025 - Jul 14, 2026

Flows

Join for free to unlock

Sector exposures

Data as of 05/31/26

Healthcare

95.37%

Unavailable

4.63%

Latest MDEV news

No content available for this fund

FAQ about MDEV

MDEV is a Passive ETF. This ETF provides exposure to Equally Weighted Equities.

MDEV tracks the Indxx Global Medical Equipment Index NTR - USD, through a full replication replication method.

MDEV carries a total expense ratio (TER) of 0.7%, indicating the annual cost for holding the fund.

MDEV was introduced to the market on June 23, 2021. It trades on United States

First Trust Indxx Medical Devices ETF, MDEV, is provided by First Trust. Learn more about First Trust here.

MDEV oversees €2.6M in assets as of July 14, 2026.

MDEV follows a distributing dividend policy, meaning it pays out income to investors. As of July 14, 2026, its 12-month trailing yield was 0.11%.

As of May 31, 2026, MDEV has significant geographic allocations in USA, Japan and Denmark.

As of May 31, 2026, MDEV focuses largely on Healthcare.

As of May 31, 2026, MDEV holds 48 positions in its portfolio, with 35.10% of assets concentrated in its top 15 holdings.

As of May 31, 2026, MDEV top three holdings include Demant A/S, West Pharmaceutical Services, Inc. and Waters Corp..

The base currency of MDEV is USD.

Top 10 holdings

Data as of 05/31/26

Demant A/S

2.54%

West Pharmaceutical Services, Inc.

2.53%

Waters Corp.

2.44%

Agilent Technologies, Inc.

2.43%

LivaNova Plc

2.42%

DexCom, Inc.

2.40%

Olympus Corp.

2.37%

Edwards Lifesciences Corp.

2.32%

Sonova Holding AG

2.31%

Revvity, Inc.

2.30%

Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:

More fund data
Compare up to 3 funds
More screener filters
Edit screener columns from 100+ metrics
Watchlists for saving your research
Portfolio construction and analysis
Personal dashboard for live monitoring

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight

The ETF Industry Is Evolving Fast

First Trust Indxx Medical Devices ETF

FAQ about MDEV

Essentials

About Trackinsight

ETF TOOLS

PLATFORM

ETF NEWS & RESEARCH

PROFESSIONAL SOLUTIONS

SOLUTIONS FOR

CONTACT US